Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Some super-smart dogs can pick up new words just by eavesdropping - 2Find the Interesting Universe of Computerized reasoning: the Capability of man-made intelligence
- 3Fundamental Venture The board Apparatuses for Remote Groups
- 4Space Condos to Lift Your Metropolitan Living
- 5Watch South Korean startup Innospace attempt its 1st-ever orbital launch today
- FDA claims on COVID-19 vaccine safety are unsupported by reliable data – and could severely hinder vaccine access
- 3 Must-Change Settings for iPhone Clients: Safeguard Yourself !
- IDF finds weapon of slain hostage Capt. Daniel Perez in booby-trapped Gaza compound
- A Manual for Well known Western television Series
- Several Israelis attempt to cross into Gaza, escorted back to Israel by IDF
- Volcanic eruption led to the Black Death, new research suggests
- Why the weirdest sea level changes on Earth are happening off the coast of Japan
- 'Stranger Things' made him a heartthrob. He left Hollywood anyway.
- Aluminum salts emerge as likely target as health officials scrutinize childhood vaccines
